Skip to main content

Table 2 Laboratory findings and comparison between rebleeding and no-rebleeding group

From: Development and validation of a model to predict rebleeding within three days after endoscopic hemostasis for high-risk peptic ulcer bleeding

Characteristic Total Rebleeding Non-rebleeding P
N = 386 N = 48 N = 338
Hemoglobin level on admission [g/L, median (IQR)] 78.5 (64–98) 74.5 (59.5–93) 79 (66–98) 0.124
White cell count [× 109/L, median (IQR)] 7.85 (5.65–11..11) 9.35 (7.12–12.81) 7.59 (5.65–10.92) 0.019
Platelet [× 109/L, median (IQR)] 167 (116–218) 132.5 (89.5–192) 172.5 (121–219) 0.015
Blood urea nitrogen [mmol/L, median (IQR)] 8.3 (5.7–12.3) 10.25 (5.65–15.15) 8.2 (5.7–11.94) 0.092
Creatinine [μmol/L, median (IQR)] 74.2 (61.3–90.8) 72.6 (59.9–107.6) 74.9 (61.3–89.3) 0.596
Albumin [g/L, median (IQR)] 32 (27.9–37) 28.8 (24.9–32) 32.4 (28.8–37.2) 0.001
Albumin [ALB ≤ 30 g/L, No. (%)] 124 (32.1) 25 (52.1) 99 (29.3) 0.002
Prothrombin time [s, median (IQR)] 11.8 (11–13) 13.1 (11.6–16.2) 11.7 (11–12.8) 0.001
APTT, median (IQR) 28.65 (24.5–33.1) 32.15 (27.15–50.5) 28.35 (24.5–32.5) 0.001
International normalized ratio [INR > 1.5, No. (%)] 15 (3.9) 8 (16.7) 7 (2.1) 0.001